Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvancedadvt Regulatory News (ADVT)

Share Price Information for Advancedadvt (ADVT)

Share Price is delayed by 15 minutes
Get Live Data
157.50    0.00 (0.00%)
Bid:
155.00
Ask:
160.00
Spread: 5.00 (3.226%)
Market Cap: £207.92m
ADVT Live PriceLast checked at - London Stock Exchange

Intraday Advancedadvt Share Chart

Admission to AIM

10 Jan 2024 07:00

RNS Number : 1662Z
Advancedadvt Limited
10 January 2024
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM THE UNITED STATES OF AMERICA (THE "UNITED STATES" OR THE "US"), AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

 

10 January 2024

 

AdvancedAdvT Limited

 

Admission to AIM

 

AdvancedAdvT Limited (AIM: ADVT, "AdvT", the "Company"), the international software solutions provider for the business solutions, healthcare compliance, and human capital management sectors, announces the admission of its Ordinary Shares to trading on AIM. Dealings will commence at 8.00 a.m. today, Wednesday 10 January 2024, under the ticker ADVT and ISIN VGG0103J1075.

 

The Company's Admission Document is available on its website at www.advancedadvt.com.

 

Enquiries:

 

AdvancedAdvT Limited

Vin Murria, Chairperson

Gavin Hugill, Chief Financial Officer

c/o Meare Consulting

Singer Capital Markets (Nominated Adviser and Broker)

Tel: 020 7496 3000

Philip Davies / Asha Chotai / Sam Butcher

KK Advisory (Investor Relations)

Tel: 020 7039 1901

Kam Bansil 

 

Meare Consulting 

Adrian Duffield

Tel: 07990 858548

 

Note to Editors

 

AdvancedAdvT Limited (AdvT) provides software solutions and platforms across two business transformational areas: business solutions & healthcare compliance, and human capital management.

 

The Group's operations are IBSS (financial management software), CHKS (AI based healthcare intelligence compliance and accreditation software), Retain (global resource planning and talent management software) and WFM (workforce management software provider).

 

AdvT is an agent for change. The Group enables the delivery of Artificial Intelligence ("AI"), data analytics and business intelligence, all of which are key future drivers for growth in these sectors where long term digitisation trends are set to transform the workplace for professionals. 

 

AdvT is developing both organically and through acquisitions, by expanding its presence across adjacent markets, geographical boundaries and digital sectors.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDBGDBLSGDGSC
Date   Source Headline
9th Jun 20223:14 pmRNSForm 8.3 -M&C SAATCHI
9th Jun 202211:33 amRNSForm 8.5 (EPT/RI)
8th Jun 20224:48 pmRNSForm 8.3 - AdvancedAdvT Limited
8th Jun 20222:35 pmRNSForm 8.3 - M&C Saatchi PLC
8th Jun 202210:10 amRNSForm 8.5 (EPT/RI)
7th Jun 202210:04 amRNSForm 8.5 (EPT/RI)
6th Jun 202212:00 pmRNSValuation of competing proposals for M&C Saatchi
6th Jun 202211:38 amRNSForm 8.5 (EPT/RI)
30th May 202211:52 amRNSForm 8.5 (EPT/RI)
26th May 20229:25 amRNSForm 8.5 (EPT/RI)
25th May 20226:18 pmRNSForm 8.5 (EPT/RI) Replacement announcement
25th May 202212:42 pmRNSForm 8.3 - AdvancedAdvT Limited
25th May 202211:05 amRNSForm 8.5 (EPT/RI)
24th May 20224:28 pmRNSForm 8.3 - AdvancedAdvT Limited
24th May 20222:36 pmRNSForm 8.3 - M&C SAATCHI
24th May 202212:12 pmRNSForm 8.3 - AdvancedAdvT Limited
23rd May 20222:51 pmRNSForm 8.3 - M&C SAATCHI
23rd May 20222:29 pmRNSForm 8.3 -NEXT FIFTEEN COMMUNICATIONS GROUP PLC
23rd May 202211:46 amRNSForm 8.5 (EPT/RI)
23rd May 20227:00 amRNSResponse to press comment
20th May 20226:18 pmRNSOffer for M&C Saatchi plc: No increase statement
20th May 20227:17 amRNSResponse to Next Fifteen offer for M&C Saatchi
19th May 20229:42 amRNSForm 8.5 (EPT/RI)
18th May 20222:34 pmGNWForm 8.3 - [ADVANCEDADVT LIMITED - 17 05 2022] - HHL
18th May 202212:23 pmRNSResponse to Rejection from the M&C Saatchi Board
18th May 202211:13 amRNSForm 8.5 (EPT/RI)
18th May 20227:57 amRNSCrux Asset Management Limited Letter of Intent
17th May 202212:03 pmRNSForm 8.5 (EPT/RI)
17th May 20227:01 amRNSOffer for M&C Saatchi plc
17th May 20227:00 amRNSDirector Changes
16th May 202212:26 pmGNWForm 8.3 - [ADVANCEDADVT LIMITED - 13 05 2022] - HHL
16th May 202210:27 amRNSForm 8.5 (EPT/RI)
13th May 20223:14 pmGNWForm 8.3 - [ADVANCEDADVT LIMITED - 12 05 2022] - HHL
13th May 20229:00 amRNSForm 8.5 (EPT/RI)
12th May 20229:02 amRNSForm 8.5 (EPT/RI)
11th May 20229:37 amRNSForm 8.5 (EPT/RI)
10th May 20225:54 pmRNSHolding(s) in Company
10th May 20221:29 pmRNSForm 8.3 - Advancedadvt Limited
10th May 202212:55 pmGNWForm 8.3 - [AdvancedAdvT Limited - 09 05 2022] - (HHL)
10th May 20229:04 amRNSForm 8.5 (EPT/RI)
10th May 20227:00 amRNSFurther Extension of "Put Up or Shut Up" Deadline
9th May 20223:15 pmRNSForm 8.3 - Advancedadvt Limited
9th May 20222:52 pmRNSForm 8.3 - Advancedadvt Limited
9th May 202211:49 amRNSForm 8.5 (EPT/RI)
6th May 202212:05 pmRNSForm 8.3 - Advancedadvt Limited
6th May 202211:07 amRNSForm 8.5 (EPT/RI)
5th May 20222:52 pmRNSForm 8.3 - M&C SAATCHI
5th May 202211:59 amRNSForm 8.3 - Advancedadvt Limited
5th May 20228:58 amRNSForm 8.5 (EPT/RI)
4th May 202212:57 pmRNSForm 8.3 - AdvancedAdvT Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.